Showing results (161-170 of 307) with videos related to

Sort By:
Pageof 31
Helicobacter|December 22, 1999
Helicobacter pylori vaccine development and use: a cost-effectiveness analysis using the Institute of Medicine MethodologyM F Rupnow, D K Owens, R Shachter, et al.
Endoscopy|August 21, 2003
Setting up a quality assurance program in endoscopyG Naylor, L Gatta, A Butler, et al.
Gut|December 1, 1979
Clinical relevance of an unfused pancreatic duct systemC J Mitchell, D J Lintott, W S Ruddell, et al.
Gut|August 1, 1993
Failure of colonoscopic surveillance in ulcerative colitisD A Lynch, A J Lobo, G M Sobala, et al.
Lancet (London, England)|August 31, 1999
Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trialB J Rembacken, A M Snelling, P M Hawkey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 24, 2001
Recurrent nonmenstrual toxic shock syndrome: clinical manifestations, diagnosis, and treatmentM M Andrews, E M Parent, M Barry, et al.
Helicobacter|June 26, 1999
Helicobacter pylori and gastric cancer: what are the benefits of screening only for the CagA phenotype of H. pylori?R A Harris, D K Owens, H Witherell, et al.
Laboratory Animal Science|May 20, 1999
Rhesus monkey (Macaca mulatta) model of Helicobacter pylori: noninvasive detection and derivation of specific-pathogen-free monkeysJ V Solnick, D R Canfield, S Yang, et al.
Helicobacter|March 1, 1996
The influence of Helicobacter pylori status on circulating levels of the coagulation factors fibrinogen, von Willebrand factor, factor VII, and factor VIIIA M Carter, P Moayyedi, A Catto, et al.
Gastrointestinal Radiology|January 1, 1986
Ultrasound detection of choledocholithiasis: prospective comparison with ERCP in the postcholecystectomy patientH J O'Connor, I Hamilton, W R Ellis, et al.
Pageof 31